Lack of relationships between cumulative methylprednisolone dose and bone mineral density in healthy men and postmenopausal women with chronic low back pain

Clinical Rheumatology

Volumn 22, Issue 1, 2003, Pages 12-17

  Dubois, E F ^a   Wagemans, M F ^a   Verdouw, B C ^a   Zwinderman, A H ^b   Van Boxtel, C J ^b   Dekhuijzen, P N R ^c   Schweitzer, D H ^a  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMD; Cumulative dose; Depot formulation; Epidural methylprednisolone

Indexed keywords

ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENDOCRINE FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW BACK PAIN; MALE; OSTEOPENIA; OSTEOPOROSIS; OUTCOMES RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BINDING; SEX ROLE; SPINE; STATISTICAL SIGNIFICANCE; BLOOD; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECT; MIDDLE AGED;

AGED; BONE DENSITY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LOW BACK PAIN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; POSTMENOPAUSE;

EID: 0038204689     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0648-3     Document Type: Article

References (29)

1. Leidig-Bruckner G, Minne HW, Schlaich C et al. (1997) Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res 12: 663-75
2. Koes BW, Scholten RJ, Mens JM, Bouter LM (1997) Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis 56: 214-23
3. van Kleef M, Barendse GA, Kessels A, Voets HM, Weber WE, de Lange S (1999) Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine 24: 1937-1742
4. Benzon HT (1986) Epidural steroid injections for low back pain and lumbosacral radiculopathy.Pain 24: 277-95
5. Goupille P, Jayson MI, Valat JP, Freemont AJ (1998) The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum 28: 60-71
6. LoCascio V, Bonucci E, Imbimbo B et al. (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8: 39-51
7. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325: 544-50
8. Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP (2001) Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. J Bone Miner Res 16: 104-12
9. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15: 993-1000
10. Rose JQ, Jusko WJ (1979) Corticosteroid analysis in biological fluids by high-performance liquid chromatography. J Chromatogr 162: 273-80
11. Oosterhuis B, ten Berge RJ, Sauerwein HP, Endert E, Schellekens PT, van Boxtel CJ (1984) Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man. J Pharmacol Exp Ther 229: 539-46
12. WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series. Geneva: World Health Organization
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-97
14. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults (1998) Arch Intern Med 158: 1855-67
15. Dubois EF, Röder E, Dekhuijzen PN, Zwinderman AE, Schweitzer DH (2002) Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest 121: 1456-63
16. Tenenhouse A, Joseph L, Kreiger N et al. (2000) CaMos Research Group. Canadian Multicentre Osteoporosis Study. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (Ca-Mos). Osteoporos Int 11: 897-904
17. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van 't Hof MA, Lemmens JA (1993) Low-dose prednisone induces rapid reversal axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119: 963-8
18. Sambrook PN, Kelly PJ, Keogh AM et al. (1994) Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 13: 116-20
19. Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48: 535-8
20. Manolagas SC, Weinstein RS (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 7: 1061-66
21. Wong CA, Walsh LJ, Smith CJ et al. (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355: 1399-1403
22. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS (2001) Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345: 989-91
23. Greendale GA, Edelstein S, Barrett-Connor E (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 12: 1833-43
24. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83: 2266-74
25. Malacara JM, Fajardo ME, Nava LE (2001) Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids 66: 559-67
26. Fineberg SE (2000) Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study. Drugs Aging 17: 453-61
27. Barrett-Connor E, Mueller JE, von Muhlen DG, Laughlin GA, Schneider DL, Sartoris DJ (2000) Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85: 219-23
28. Kley HK, Edelmann P, Kruskemper HL (1980) Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism 29: 1041-45
29. Kley HK, Deselaers T, Peerenboom H, Kruskemper HL (1980) Enhanced conversion of androstenedione to estrogens in obese males. J Clin Endocrinol Metab 51: 1128-32